Literature DB >> 17159983

An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses.

Laurence Arbibe1, Dong Wook Kim, Eric Batsche, Thierry Pedron, Bogdan Mateescu, Christian Muchardt, Claude Parsot, Philippe J Sansonetti.   

Abstract

Phosphorylation of histone H3 at Ser10 increases chromatin accessibility to transcription factor NF-kappaB on a subset of genes involved in immune responses. Here we report that a bacterial pathogen abrogated phosphorylation of histone H3 to 'shape' the transcriptional responses of infected host cells. We identify the Shigella flexneri protein effector OspF as a dually specific phosphatase that dephosphorylated mitogen-activated protein kinases in the nucleus, thus preventing histone H3 phosphorylation at Ser10 in a gene-specific way. That activity of OspF enabled shigella to block the activation of a subset of NF-kappaB-responsive genes, leading to compromised recruitment of polymorphonuclear leukocytes to infected tissues. S. flexneri has thus evolved the capacity to precisely modulate host cell epigenetic 'information' as a strategy for repressing innate immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159983     DOI: 10.1038/ni1423

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  157 in total

1.  Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis.

Authors:  Max Tze-Han Huang; Brittany L Mortensen; Debra J Taxman; Robin R Craven; Sharon Taft-Benz; Todd M Kijek; James R Fuller; Beckley K Davis; Irving Coy Allen; Willie June Brickey; Denis Gris; Haitao Wen; Thomas H Kawula; Jenny Pan-Yun Ting
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Bacterial effectors target the plant cell nucleus to subvert host transcription.

Authors:  Joanne Canonne; Susana Rivas
Journal:  Plant Signal Behav       Date:  2012-02-01

Review 3.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 4.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

5.  Tools and landscapes of epigenetics.

Authors:  Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2010-07       Impact factor: 25.606

Review 6.  Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.

Authors:  Pedro Escoll; Sonia Mondino; Monica Rolando; Carmen Buchrieser
Journal:  Nat Rev Microbiol       Date:  2015-11-23       Impact factor: 60.633

7.  Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner.

Authors:  Mingyu Hou; Wenhui Wang; Feizi Hu; Yuanxing Zhang; Dahai Yang; Qin Liu
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

8.  Natural molecules induce and synergize to boost expression of the human antimicrobial peptide β-defensin-3.

Authors:  Emmanuel Sechet; Erica Telford; Clément Bonamy; Philippe J Sansonetti; Brice Sperandio
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.

Authors:  Daniel V Zurawski; Karen L Mumy; Luminita Badea; Julia A Prentice; Elizabeth L Hartland; Beth A McCormick; Anthony T Maurelli
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.